- Home
- SOUN vs ZLAB Comparison
SOUN vs ZLAB Comparison
Compare SOUN & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOUN | ZLAB |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SOUN | ZLAB |
|---|---|---|
| Price | $7.01 | $25.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $15.00 | ★ $49.60 |
| AVG Volume (30 Days) | ★ 34.6M | 983.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.08 | 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $40.76 | $9.75 |
| Revenue Next Year | $20.02 | $26.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $5.65 | $15.96 |
| 52 Week High | $22.17 | $35.45 |
Technical Indicators
Market Signals| Indicator | SOUN | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 52.46 | 73.93 |
| Support Level | $5.95 | $16.98 |
| Resistance Level | $7.98 | $26.66 |
| Average True Range (ATR) | 0.44 | 1.18 |
| MACD | 0.06 | 0.57 |
| Stochastic Oscillator | 53.41 | 87.07 |
Price Performance
Historical ComparisonAbout SOUN SoundHound AI Inc
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.